Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm. (2020)
Attributed to:
Alignment of Synthesis, Medicinal Chemistry and Structural Genomics to Accelerate UK Drug Discovery: Network SMS-Drug
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.9b00748
PubMed Identifier: 31990523
Publication URI: http://europepmc.org/abstract/MED/31990523
Type: Journal Article/Review
Volume: 15
Parent Publication: ACS chemical biology
Issue: 3
ISSN: 1554-8929